Medical Developments International | MVP - Zinsaufwendungen Für Schuld

Aktienkurs
0.43
Täglich Wechseln
-0.01 -2.27%
Monatlich
11.69%
Jährlich
-26.50%
Q2 Prognose
0.43




Zinsaufwendungen Für Schuld Veränderung Datum
Akebia Therapeutics 362.52M 357.69M 2026-03
Alaunos Therapeutics USD 1.07M 215K 2023-06
Avita Medical AUD 1.25M 100K 2025-06
Clinuvel Pharmaceuticals AUD 2.49M 51.97K 2025-06
Dianthus Therapeutics USD 4.44M 263K 2024-09
Genetic Signatures AUD 18K 17K 2024-06
Ionis Pharmaceuticals USD 17M 1000K 2026-03
Medical Developments International AUD 18K 3K 2025-06
Neuren Pharmaceuticals AUD 0 0 2024-06
Organon & Co USD 128M 3M 2025-09
Paradigm Biopharmaceuticals AUD 1000 3K 2025-06
PYC Therapeutics AUD 17K 11K 2025-06
Tectonic Therapeutic USD 246.58M 246.56M 2026-03
Telix Pharmaceuticals AUD 7.62M 11.22M 2025-12
Viatris USD 120.1M 500K 2026-03
Xeris Pharmaceuticals USD 7.15M 115K 2025-12